BridgeBio Pharma, Inc. (BBIO)
76.30
-0.27
(-0.35%)
USD |
NASDAQ |
Sep 02, 10:28
BridgeBio Pharma Cash from Operations (Annual) : -445.91M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -445.91M |
| December 31, 2024 | -520.73M |
| December 31, 2023 | -527.72M |
| December 31, 2022 | -419.49M |
| December 31, 2021 | -497.93M |
| Date | Value |
|---|---|
| December 31, 2020 | -399.71M |
| December 31, 2019 | -253.59M |
| December 31, 2018 | -136.64M |
| December 31, 2017 | -40.49M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Ionis Pharmaceuticals, Inc. | -268.58M |
| Pfizer Inc. | 11.70B |
| Vertex Pharmaceuticals, Inc. | 3.631B |
| BioMarin Pharmaceutical, Inc. | 827.99M |